Equivir（GRDG Sciences）

N/A

Report date: 2023/01/16 13:58:46
NME

Base Information

Drug NameEquivir（GRDG Sciences）
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRhinovirus infectionInfluenza A virus infectionsCoronavirus Disease 2019 (COVID-19) +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlobal Research & Discovery Group Sciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesProPhase BioPharma IncProphase Labs IncGlobal Research & Discovery Group Sciences LLC
Inactive CompaniesN/A
Active IndicationsRhinovirus infectionInfluenza A virus infectionsCoronavirus Disease 2019 (COVID-19) +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A